Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it will participate in the Corporate Connect Webinar Series hosted by Webull Financial being held virtually ...
Akari Therapeutics is an oncology biotechnology company developing next-generation spliceosome payload antibody drug conjugates (ADCs). Utilizing its innovative ADC discovery platform, the Company has ...
Activated T cells play an important role in the inflammatory process. Foralumab, the only fully human anti-CD3 monoclonal antibody (mAb), binds to the T cell receptor and dampens inflammation by ...
Mean Target Price: $18.50 Median Target Price: $18.50 High/Low Range: $19.00 / $18.00 Number of Analysts: 2 Rating: Buy (1.00) — the strongest rating on the scale Analysts covering BULL see the stock ...
Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results